Worldwide Introduces Latest Additions to its Webinar Series, to Commemorate Heart Month and Rare Disease Day

Thursday, February 9, 2017 Heart Disease News
Email Print This Page Comment bookmark
Font : A-A+

MORRISVILLE, North Carolina, February 9, 2017 /PRNewswire/ --

Worldwide Clinical Trials (http://www.worldwide.com)

has announced the latest additions to its free webinar series, both taking place in February. The first of two informative sessions will address the future of heart failure research in honor of Heart Month, while the second will examine the impact of
emerging opportunities on innovative trial design and execution in rare disease clinical trials on Rare Disease Day.

On Thursday, February 16 at 11 a.m. ET, Worldwide will host its Heart Month webinar titled, "The Future in Heart Failure: Novel Therapies, Innovative Trial Designs & Stakeholder Diversity." Participants will hear from Michael Murphy, M.D., Ph.D., Chief Medical & Scientific Officer at Worldwide, and Toni Bransford, M.D., Senior Medical Director, Medical & Scientific Affairs at Worldwide. They will discuss a range of topics including emerging heart failure therapies and trial designs; how to demonstrate value when novelty is not enough; and the who, what and why of diverse stakeholders.

The next webinar in the series will celebrate Rare Disease Day on Tuesday, February 28 at 11 a.m. ET. The webinar, titled "Rare Disease Clinical Trials: An Opportunity for Differentiated Services," will be hosted by Dr. Murphy, who will be joined by Leslie Wetherell, Executive Director, Project Management, Rare Disease Franchise Lead at Worldwide. They will discuss emerging opportunities for an "outside the box" approach to both study and program design; how family engagement informs both trial design and operational strategy; and how innovative development strategies necessitate efficient, high quality program execution.

Both webinars are free to attendees. To learn more, visit http://www.worldwide.com/webinars or register directly at:

  • The Future in Heart Failure: Novel Therapies, Innovative Trial Designs & Stakeholder Diversity, February 16, 11 a.m. ET
  • Rare Disease Clinical Trials: An Opportunity for Differentiated Services, February 28, 11 a.m. ET

Connect with Worldwide Clinical Trials:

  • Tweet: @worldwidetrials commemorates Heart Month and Rare Disease Day with two free webinars
  • Follow us on Twitter: @worldwidetrials
  • Find us on LinkedIn: https://www.linkedin.com/company/worldwide-clinical-trials-inc-

About Worldwide Clinical Trials  

Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit Worldwide.com.

SOURCE Worldwide Clinical Trials



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store